Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00404937 |
Recruitment Status :
Withdrawn
First Posted : November 29, 2006
Last Update Posted : March 6, 2012
|
Sponsor:
Alcon Research
Information provided by:
Alcon Research
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
The purpose of this study is to compare the new formulation of Tobradex to the current approved formulation
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Post-surgical Inflammation | Drug: Tobradex (Antibiotic steroid combination) | Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 0 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single |
Primary Purpose: | Treatment |
Official Title: | Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle |
Study Start Date : | December 2006 |
Actual Primary Completion Date : | December 2006 |
Actual Study Completion Date : | December 2006 |
Primary Outcome Measures :
- Anterior chamber inflammation
Secondary Outcome Measures :
- Aqueous cells and flare
- ocular pain
- physician's impression of infection
- frequency of treatment failures
Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Patients scheduled for cataract extraction
Exclusion Criteria:
- Under 18 years
No Contacts or Locations Provided
ClinicalTrials.gov Identifier: | NCT00404937 |
Other Study ID Numbers: |
C-05-60 |
First Posted: | November 29, 2006 Key Record Dates |
Last Update Posted: | March 6, 2012 |
Last Verified: | September 2007 |
Additional relevant MeSH terms:
Inflammation Pathologic Processes Anti-Bacterial Agents Tobramycin, Dexamethasone Drug Combination Anti-Infective Agents Anti-Inflammatory Agents |
Glucocorticoids Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs Ophthalmic Solutions Pharmaceutical Solutions |